GEF-B
Greif, Inc.
There isn't enough reported data to score GEF-B yet.
LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
GEF-B Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Unavailable | |
| Under pressure |
GEF-B's profitability is currently healthy, but its revenue and balance sheet are under pressure. There isn't enough data to rate its cash flow.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
GEF-B PE Valuation
GEF-B has no meaningful PE right now: it lost money over the past year.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
GEF-B Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect GEF-B's earnings to grow and its profitability to improve, with its revenue holding steady.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
GEF-B Earnings Per Share
GEF-B and LCID do not have enough comparable growth data to identify a winner.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
GEF-B Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.2B | +2.7% |
| Q1 2026 | $1.1B | -23% |
| Q4 2025 | $994.8M | -21% |
| Q3 2025 | $701.3M | -51% |
| Q3 2025 | $1.1B | -22% |
| Q2 2025 | $1.4B | +1.1% |
| Q1 2025 | $1.3B | +5% |
| Q4 2024 | $1.4B | +8.3% |
GEF-B's revenue has slid since its 2022 peak: $1.2B last quarter, up 2.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 9.3% | +2.8 points |
| Q1 2026 | 3.3% | -5.3 points |
| Q4 2025 | 26% | +21 points |
| Q3 2025 | 0.7% | -8.2 points |
| Q3 2025 | 6.4% | -5.3 points |
| Q2 2025 | 8.6% | +1.4 points |
| Q1 2025 | 4.7% | -1 points |
| Q4 2024 | 8.9% | +0.3 points |
GEF-B has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over GEF-B on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
GEF-B Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $49.1M | -69% |
| Q1 2026 | $59.8M | -44% |
| Q4 2025 | -$57.4M | +$9.1M |
| Q3 2025 | $156.9M | +390% |
| Q2 2025 | $106.4M | +129% |
| Q1 2025 | -$66.5M | -$15.4M |
| Q4 2024 | $142.1M | +13% |
| Q3 2024 | $32M | -80% |
GEF-B has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
GEF-B Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +32K shares |
| 1 year | -2.8% | -1.3M shares |
| 3 years | -1.4% | -637K shares |
| 5 years | -4.9% | -2.4M shares |
| Available history | -4.4% | -2.1M shares |
GEF-B has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $2.9M |
| Q1 2026 | $19.1M |
| Q4 2025 | $128.1M |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
GEF-B Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 3.8x | Elevated |
| Q2 2025 | 3.4x | Elevated |
| Q1 2025 | 3.7x | Elevated |
| Q4 2024 | 3.5x | Elevated |
| Q3 2024 | 3.9x | Elevated |
| Q2 2024 | 4.0x | Elevated |
| Q1 2024 | 2.8x | Moderate |
| Q4 2023 | 2.4x | Moderate |
GEF-B's net debt is about 3.8 years of its operating earnings (EBITDA), about the same as a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
GEF-B Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.7 | Neutral |
| Stochastic | 33.8 | Neutral |
GEF-B's weekly RSI is 49 (neutral) and its Stochastic is 34 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
GEF-B PE vs Consumer Cyclical Sector
| Metric | GEF-B | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
GEF-B has no meaningful PE right now: it lost money over the past year.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
GEF-B Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $108.2 | 7.6% below |
| 20 week MA | $105.4 | 5.2% below |
| 50 week MA | $91.8 | 8.8% above |
| 100 week MA | $77.7 | 29% above |
| 200 week MA | $73.8 | 35% above |
GEF-B has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
GEF-B Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.6 | $48.8 | -5.4% |
| 2021 | $48.8 | $57.4 | +18% |
| 2022 | $57.4 | $77.1 | +34% |
| 2023 | $77.1 | $66.0 | -14% |
| 2024 | $66.0 | $68.6 | +3.9% |
| 2025 | $68.6 | $75.8 | +10% |
| 2026 YTD | $75.8 | $99.9 | +32% |
GEF-B has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.